A Day on the Floor: My Experience at the 2026 ISPE Aseptic Conference Expo Hall
Attending industry conferences is often associated with technical sessions and formal presentations, but meaningful insights can also emerge beyond these sessions. This testimonial, written by Khushi Dhingani, offers an observational look at the 2026 ISPE Aseptic Conference Expo Hall, emphasizing how professional insight can be gained outside traditional conference sessions. By focusing on the exhibition environment as a space for demonstration, discussion, and exchange, it frames the Expo Hall as a practical setting where current approaches to aseptic processing and pharmaceutical manufacturing are actively explored.
Testimonial from Khushi Dhingani, ISPE Student Chapter President, Massachusetts College of Pharmacy and Health Sciences
Sometimes, the most powerful learning doesn’t happen in sessions- it happens where the industry comes alive.
Attending the 2026 ISPE Aseptic Conference 2026, in Washington, D.C., with an Expo Hall pass offered me a perspective that I did not initially expect—an experience that turned out to be deeply impactful. Without attending any formal sessions, I experienced the conference in its most interactive and practical form. Instead of listening to structured presentations, I immersed myself in the environment where innovation is not just discussed but demonstrated, questioned, and continuously refined.
Walking into the Expo Hall, I immediately sensed the scale and energy of the industry. It was not just a space filled with booths; it was a live ecosystem of ideas, technologies, and professionals working toward a common goal—ensuring sterility, quality, and patient safety in pharmaceutical manufacturing. Each exhibit represented a piece of a much larger puzzle, and together, they painted a clear picture of where aseptic processing is heading.
What made this experience particularly valuable for me was the shift from theoretical understanding to real-world application. Coming from a clinical research background, I am used to working with protocols, regulatory frameworks, and trial design. However, being physically present among technologies like isolators, cleanroom solutions, contamination control systems, and real-time monitoring platforms allowed me to see how those frameworks translate into practice. It was no longer abstract—it was tangible, operational, and immediate.
As I moved from booth to booth with my boss, I engaged in conversations with industry professionals, engineers, and solution providers. These interactions became the most insightful part of my experience. Unlike structured sessions, these discussions were dynamic and personalized. I was able to ask questions, explore specific challenges, and understand how different companies approach contamination control and sterility assurance in their own environments.
Innovation is not just built in labs- it is shaped in conversations, challenged by questions, and strengthened through real-world application.
One of the recurring themes I noticed across multiple exhibitors was the strong emphasis on minimizing human intervention. Technologies are increasingly designed to reduce variability, enhance control, and create more predictable systems. Isolators, automated filling systems, and advanced monitoring tools all aim to limit one of the most critical risks in aseptic environments- human error. This reinforced something I had learned academically but never fully appreciated until now: in sterile manufacturing, even the smallest deviation can have significant consequences.
At the same time, what stood out to me was that no technology was presented as a standalone solution. Every innovation was part of a broader system—integrated with facility design, environmental monitoring, and operational workflows. This highlighted the importance of thinking in systems rather than components. Aseptic processing is not about implementing individual tools; it is about designing an interconnected framework where each element supports the other.
Another aspect that deeply resonated with me was the openness of professionals in sharing their experiences. There was a sense of collective learning- an understanding that while companies may differ in approach, the ultimate goal remains the same. Conversations often went beyond product demonstrations and into discussions about challenges, regulatory expectations, and future directions. This gave me insight not only into current technologies but also into the mindset of the industry.
Being in that environment also made me reflect on the role of regulatory frameworks such as EU GMP Annex 1. While I had studied these guidelines academically, seeing how companies interpret and implement them in real-world systems was incredibly valuable. It became clear that compliance is not just about meeting requirements—it is about designing processes that inherently align with those standards.
Technology can reduce risk, but responsibility defines outcomes.
This realization stayed with me throughout the day. Even with advanced automation and sophisticated systems, the success of aseptic processing ultimately depends on how well people understand and execute their roles. Training, awareness, and a strong culture of quality remain essential. The Expo Hall did not just showcase machines—it highlighted the balance between innovation and human accountability.
Another important takeaway for me was the level of collaboration that exists within the pharmaceutical manufacturing ecosystem. The Expo Hall brought together vendors, engineers, quality experts, and regulatory professionals, all contributing to different aspects of the same goal. It made me appreciate how interconnected the industry truly is. Innovation is not developed in isolation- it is built through partnerships, shared knowledge, and continuous dialogue.
Since I did not attend formal sessions, my learning was entirely self-directed. I chose where to spend my time, which conversations to engage in, and what topics to explore. This made the experience more intentional and personal. I was not passively absorbing information; I was actively seeking it. This approach allowed me to connect concepts in a way that felt more meaningful and relevant to my own interests.
As someone currently building a career in clinical investigations, this experience helped me bridge an important gap. It allowed me to see how clinical concepts eventually translate into manufacturing realities. The decisions made during drug development are ultimately implemented through systems, processes, and technologies like the ones I observed on the Expo Hall floor. This connection gave me a more holistic understanding of the pharmaceutical lifecycle.
Being part of an event organized by the ISPE further emphasized the importance of platforms that bring together diverse expertise. The Expo Hall, in particular, demonstrated how knowledge exchange can happen outside formal settings. It showed that learning is not confined to presentations—it happens in conversations, observations, and shared experiences.
What we build in sterile manufacturing is not just a process- it is trust that reaches the patient.
Reflecting on my one-day experience, I realized that the Expo Hall offered something uniquely valuable. It provided a real-time snapshot of the industry- where it stands today and where it is heading. Even without attending sessions, I walked away with a deeper understanding of aseptic processing, a stronger appreciation for the complexity of sterile manufacturing, and a clearer vision of how I want to grow within this field.
Attending the 2026 ISPE Aseptic Conference in this way reminded me that learning does not always follow a structured path. Sometimes, it comes from being present in the right environment, asking thoughtful questions, and observing with curiosity and intent. And in many ways, that kind of learning leaves the strongest impact.
